Ki‐67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: Correlation with steroid receptors, epidermal‐growth‐factor receptor and cathepsin D
暂无分享,去创建一个
J. Foekens | J. Klijn | E. Berns | S. Henzen‐Logmans | M. van der Burg | E. Fieret | Jan G. M. Klijn | Sonja C. Henzen‐Logmans | Elly J. H. Fieret | Els M. J. J. Berns | Maria E. L. van der Burg
[1] J. Foekens,et al. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Foekens,et al. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study. , 1993, European journal of cancer.
[3] J. Foekens,et al. Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay. , 1992, British Journal of Cancer.
[4] J. Foekens,et al. Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer , 1992, International journal of cancer.
[5] J G Klijn,et al. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.
[6] R. Leake,et al. Epidermal growth factor receptors (EGFR) in human ovarian cancer. , 1991, British Journal of Cancer.
[7] G. Scambia,et al. Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor. , 1991, British Journal of Cancer.
[8] T. H. van der Kwast,et al. Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears. , 1991, Journal of clinical pathology.
[9] B. Slotman,et al. Endocrine factors in common epithelial ovarian cancer. , 1991, Endocrine reviews.
[10] R. Bast,et al. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. , 1991, American journal of obstetrics and gynecology.
[11] T. Bauknecht,et al. Clinical significance of oncogenes and growth factors in ovarian carcinomas , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[12] O. Kallioniemi,et al. Steroid receptors and Ki‐67 reactivity in ovarian cancer and in normal ovary: Correlation with dna flow cytometry, biochemical receptor assay, and patient survival , 1990, The Journal of pathology.
[13] H. Rochefort,et al. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. , 1990, Molecular endocrinology.
[14] R. Bast,et al. The Role of Peptide Growth Factors in Epithelial Ovarian Cancer , 1990, Obstetrics and gynecology.
[15] M. Tattersall,et al. Immunohistochemical determination of tumour growth fraction in human ovarian carcinoma , 1989, British journal of obstetrics and gynaecology.
[16] H. Rochefort,et al. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. , 1988, Cancer research.
[17] T. Bauknecht,et al. Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. , 1988, Gynecologic oncology.
[18] Marcel Garcia,et al. Estrogen‐induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis? , 1987, Journal of cellular biochemistry.
[19] W. Franklin,et al. Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast , 1987, Cancer.
[20] A. V. van Lindert,et al. DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas. , 1987, Pathology, research and practice.
[21] G. Sutton,et al. Estrogen and progesterone receptors in epithelial ovarian malignancies. , 1986, Gynecologic oncology.
[22] H. Rochefort,et al. A secreted glycoprotein induced by estrogen in human breast cancer cell lines , 1980, Cell.